drugset / Trial / NCT00003292
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
Phase 2
Terminated
7 enrolled
SWOG Cancer Research Network
Eastern Cooperative Oncology Group · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.
Timeline
- Start
- 1998-07
- Primary completion
- 2004-01
- Completion
- 2004-01
Outcome
Outcome not reported
Stopped (Enrollment): “lack of accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ifosfamide | Small molecule | — | Intravenous |